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1084Objectives: In patients with high-risk hypoplastic left heart syndrome (HLHS), the Norwood operation (NW) in
the neonatal period still results in high mortality comparedwith other cardiac surgery. Bilateral pulmonary artery
banding (bPAB), a very effective initial procedure for HLHS, for which the specific evaluation is as yet unsat-
isfactory, was performed, and we report our findings in the present study.
Methods:We have performed bPAB since 2006. A total of 17 patients with HLHS or a variant underwent bPAB
before the NW. Echocardiography was performed between bPAB and the NW, and the flow acceleration just
after bPAB and before NW was evaluated. Before the NW, a catheter examination was also performed.
Results: bPAB was performed at 6.6  0.6 days of age, and the NWat 130 88 days. The patients’ mean body
weight (BW) was 2.5  0.4 kg at bPAB and 4.0  1.1 kg at the NW. The length of the tape for bPAB was 9.9 
0.6 mm in the right pulmonary artery (RPA) and 9.4  0.6 mm in the left (LPA) because the RPAwas usually
wider than the LPA. The tape width was 2 mm in all cases. The catheter examination was performed at 95  85
days after bPAB. The arterial oxygen saturation (SaO2) was 71%  8.6%. Multivariate regression analysis re-
vealed that SaO2 was estimated well using 4 factors: the banding size of the RPA, BWat bPAB, BWat NW, and
BW in the period between bPAB and catheter examination (R2 ¼ 0.79). Echocardiography just after bPAB
showed that the blood flow at the bPAB had accelerated to 3.0  0.8 m/s in the RPA and 3.3  0.8 m/s in
the LPA (P ¼ .004). The estimated pressure gradient was 39.2  17.6 mm Hg in the RPA and 46.1  23.0
mm Hg in the LPA (P ¼ .006). The blood flow at bPAB was accelerated to 3.7  0.7 m/s in the RPA and
4.0  0.6 m/s in the LPA before NW (P ¼ .013). The estimated pressure gradient was 62.6  27.6 mm Hg
in the RPA and 56.1  19.6 mm Hg in the LPA before NW (P ¼ .014). The catheter examination revealed
mean wedge pressures of 18.0  7.2 mm Hg for the RPA and 16.2  4.3 mm Hg for the LPA. The operative
mortality rate was 0%. One patient required a repeat operation to adjust the bPAB, and prolonged pleural effu-
sion was observed in 1 case.
Conclusions: The postoperative SaO2 after bPAB correlated closely with the banding size and BWat bPAB, NW
and during the period after bPAB. Because the mean PA pressure before NWwas low enough for single ventric-
ular circulation, the bPAB in this study was an effective option for high-risk patients undergoing HLHS or a var-
iant. We believe the bPAB sizes used were suitable and were determined as follows: BW plus 7 mm for the LPA
and BW plus 7.5 mm for the RPA. (J Thorac Cardiovasc Surg 2010;140:1084-91)Hypoplastic left heart syndrome (HLHS) is still a chal-
lenge for cardiac surgeons.1-3 Norwood performed his
first palliation procedure, the Norwood operation (NW),
in 1981, and it has been a standard procedure for first-
step palliation since then.4 This was a great breakthrough
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The Journal of Thoracic and Cardiovascular Surwith HLHS.5 Because the postoperative management
and medical machinery surrounding surgery have greatly
improved, its mortality has recently been decreasing.6-9
In a high-risk neonate with HLHS, however, the mortal-
ity is still high. According to the published data, a low
birth weight, prematurity, preoperative shock, renal fail-
ure, a small ascending aorta, restrictive atrial communi-
cation, extracardiac abnormalities, and chromosomal
abnormalities are risk factors for mortality after the
NW operations.3,10-14
Bilateral pulmonary artery (PA) banding (bPAB) has re-
cently attracted attention, because it is less invasive than sur-
gery requiring cardiopulmonary bypass support.13-17 In
particular, in a neonate with high-risk HLHS, bPAB can be
an initial approach preceding theNW,which can then be per-
formed relatively safely. We have performed bPAB in 17 pa-
tients in the high-risk HLHS group, followed by the NW
since 2006. We evaluated our outcomes in the present study.gery c November 2010
Abbreviations and Acronyms
BCPS ¼ bidirectional cavopulmonary shunt/
bidirectional Glenn operation
bPAB ¼ bilateral pulmonary artery banding
BTS ¼ Blalock-Taussig shunt
BW ¼ body weight
HLHS ¼ hypoplastic left heart syndrome
LPA ¼ left pulmonary artery
NW ¼ Norwood operation
PA ¼ pulmonary artery
PDA ¼ patent ductus arteriosus
RPA ¼ right pulmonary artery
TEE ¼ transesophageal echocardiography
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The Scientific Committee of our hospital approved the present study.
We performed 17 cases of bPAB from January 2006 to October 2009 and
evaluated the data retrospectively.
Patient Characteristics
The patient characteristics, including the diagnoses and risk factors, are
listed in Table 1.
bPAB Operation
The bPAB operation was performed with the oxygen saturation (SaO2)
maintained at about 80%. The tape for bPAB was made of Gore-Tex tub-
ing. The tube was cut longitudinally to create a strip 2 mm wide for all
cases. The length of the strip needed for the left PA (LPA) was determined
by measuring its central portion to 7 mm and adding the patient’s BW, ex-
pressed as 1 mm for each 1 kg (e.g., for a 3-kg infant, the length of this cen-
tral portion was 7 mm plus 3 mm for a length of 10 mm). This was markedTABLE 1. Profile of patients with hypoplastic left heart syndrome
Diagnosis
Aortic
valve
Mitral
valve AAo (mm)
Gestation
age (wk
HLHS AA MA 1.7 37
HLHS AA MS 1.8 41
HLHS AA MA 1.5 40
HLHS AA MA 2 36
HLHS AS MA 7 39
Hypo LV, CoA AS MS 6.3 38
HLHS AA MA 1.3 39
Hypo LV, CoA AS MS 7.2 37
HLHS AS MS 5.2 38
HLHS AA MA 1.6 38
HLHS AS MS 4.3 38
HLHS AA MA 2.2 40
HLHS AS MS 3.8 40
HLHS AS MS 4.7 37
HLHS AA MS 5 39
TA(2C), CoA AS — 5.9 39
HLHS AA MS 1.3 38
AAo, Ascending aorta; HLHS, hypoplastic left heart syndrome; AA, aortic atresia; MA, mi
stenosis; AS, aortic stenosis; TA, tricuspid atresia; bPAB, bilateral pulmonary artery bandi
The Journal of Thoracic and Caroff with a marker suture at each end. If the baby’s weight was not an exact
number of kilograms, it was rounded to the nearest 0.5 mm (0.5 kg), with
a fraction of 0.25 kg and 0.75 kg rounded down and up, respectively; thus,
3.3 kg was rounded to 3.5 kg (converted to 3.5 mm) and 3.25 kg was
rounded to 3.0 kg (converted to 3.0 mm). Thus, the lengths of the
marked-off central portions differed from each other by amounts divisible
by 0.5 mm. During bPAP, the fraction of inspiratory oxygen was kept at
21%, as was the room air. Intraoperative transesophageal echocardiogra-
phy was performed to detect any flow reduction in the pulmonary vein
and, if possible, flow acceleration at the bPAB site.
If the SaO2 was more than 85% and flow acceleration was less than
2 m/s, the PA band was tightened by intervals of 0.5 mm, alternating,
from right to left. In contrast, if the SaO2 became less than 75%, the
PA band was loosened in reverse order. The ideal goal of flow acceleration
is greater than 3 m/s during the operation; however, it often remains within
the range of 2 to 3 m/s, which is acceptable.
Aristotle Score
The comprehensive Aristotle score was estimated assuming that the pa-
tients underwent the NW in the neonatal period. The actual comprehensive
Aristotle score was calculated after they had undergone the NW in infancy
after bPAB.
Examination
Echocardiography was performed arbitrarily, and cardiac catheteriza-
tions were done before the NW.
Statistical Analysis
The data are presented as numbers and percentages or as the mean 
standard deviation. All statistical tests were 2-sided. Statistical calculations
were performed using the StatView software package, version 5.0 (SAS
Institute, Inc, Cary, NC).RESULTS
Demographics
Of the 17 patients, 10 (56%) had aortic atresia, and 9 of
the infants with aortic atresia (53%) had a small ascendingal
)
Birth
weight (g) Other risk factors
2664
2120
2200 Jacobsen syndrome
2454 Biliary atresia
3342 bPAB in previous hospital
2450 Cleft lip and palate, bPAB in previous hospital
2462 Jacobsen syndrome, cor triatriatum, DIC
2368 Esophageal atresia, omphalocele
2812 Ductal shock
2633
2530 Restrictive PFO
3301 Restrictive PFO
2232 DIC
2587 Sotos syndrome, renal failure
2769 Jacobsen syndrome
2785 High-flow shock
2643
tral atresia; Hypo LV, hypoplastic left ventricle; CoA, coarctation of aorta; MS, mitral
ng; DIC, disseminated intravascular coagulation; PFO, patent foramen ovale.
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Daorta (2 mm) (Table 1). The birth weight in 7 patients
(41%) was less than 2.5 kg. Chromosomal abnormalities
were found in 4 patients. Of these 4, 3 were Jacobsen syn-
drome and 1 was Sotos syndrome. Major digestive tract dis-
ease was seen in 2 patients: esophageal atresia and biliary
atresia. Two patients had symptoms of shock when they
had arrived at our hospital.
bPAP Operation
bPAB was performed at 6.6  0.6 days of age, and the
NW at 130  88 days. The BW was 2.5  0.4 kg at
bPAB and 4.0  1.1 kg at the NW. The actual tape length
for bPAB was 9.9  0.6 mm in the right PA (RPA) and
9.4 0.6 mm in the LPA, because the RPAwas often wider
than the LPA. The tape width was 2 mm in all cases. Of the
17 patients, 16 underwent the NW after bPAB; the remain-
ing child had developed a substantial pleural effusion. This
patient had had a very small patent foramen ovale at birth,
and balloon atrial septotomy had not been effective. Cardio-
pulmonary bypass was therefore used for atrial septal defect
enlargement when bPAB was performed. Only for this
patient was cardiopulmonary bypass used.
Echocardiography
Echocardiography just after bPAB showed that the blood
flow at bPAB had accelerated to 3.0  0.8 m/s in the RPAFIGURE 1. Accelerated blood flow velocity at bilateral pulmonary artery bandi
the Norwood operation (NW), both determined echocardiographically. LPA, lef
1086 The Journal of Thoracic and Cardiovascular Surand 3.3  0.8 m/s in the LPA (P ¼ .004) (Figure 1). The
estimated pressure gradient was 39.2  17.6 mm Hg in
the RPA and 46.1  23.0 mm Hg in the LPA (P ¼ .006).
The blood flow at bPAB had accelerated to 3.7  0.7 m/s
in the RPA and 4.0  0.6 m/s in the LPA before the NW
(P ¼ .013). The estimated pressure gradient was 62.6 
27.6 mm Hg in the RPA and 56.1  19.6 mm Hg in the
LPA before the NW (P ¼ .014).Catheter Examination
A catheter examinations were performed 95  85 days
after bPAB and just before the NW. The SaO2 was
71%  8.6%. This examination revealed a mean wedge
pressure of 18.0  7.2 mm Hg for the RPA and 16.2 
4.3 mm Hg for the LPA (Table 2).PA Band Size
Univariate regression analysis revealed that the approxi-
mate LPA band size could be determined from the BW at
bPAB (R2¼ 0.40) (Figure 2). A linear approximation curve
(Figure 2, thick line) was drawn on the LPA graph. The area
between the 2 parallel thin lines, 1 mm apart, with the thick
line parallel to, and equidistant from both, included most of
the plotted points (15 of 17 points, 88%). The data shownng (bPAB) sites and estimated pressure gradients just after bPAB and before
t pulmonary artery; RPA, right pulmonary artery; PG, pressure gradient.
gery c November 2010
TABLE 2. Data of catheter examination performed just before
Norwood operation
Catheter examination data
LPA pressure (LPV wedge pressure) 15.9  4.1 mm Hg
RPA pressure (RPV wedge pressure) 18.0  7.2 mm Hg
PA index 186  93 mm2/m2
Rp 2.2  1.1 Wood·U
SaO2 71%  8.6%
LPA, Left pulmonary artery; LPV, left pulmonary vein; RPA, right pulmonary artery;
RPV, right pulmonary vein; Rp, pulmonary vascular resistance; SaO2, arterial oxygen
saturation.
Kitahori et al Congenital Heart Disease
C
H
Don this graph indicated that the LPA band size was adjusted
to within 0.5 mm of the BW plus 7 mm.
Estimated SaO2 at NW
Multivariate regression analysis revealed that the SaO2
just before NW could be estimated precisely using 4 factors:
the band size of the RPA (x1), the BWat bPAB (x2), the BW
at the NW (x3), and the interval between bPAB and the cath-
eter examination (x4). The correlation between the actual
SaO2 and the estimated SaO2 was very high (R
2 ¼ 0.79)
(Figure 3).
The multiple regression equation was as follows:
Estimated SaO2 ¼ 4:8144  x1þ8:5828  x2þ0:8611
 x30:0779  x4
Ductus Arteriosus Patency
To maintain a patent ductus arteriosus (PDA), stenting
was performed in 4 patients; in 1, stent migration occurred.
In the other 14 cases, lipoprostaglandin E1 was continu-
ously administered to maintain the PDA. No patient had
any major complication related to lipoprostaglandin E1 use.
Aristotle Comprehensive Score
The Aristotle score, estimated on the assumption that the
NW was performed during the neonatal period, was a littleFIGURE 2. Results of univariate regression analysis between bilateral pulmona
curve shown as thick line. Two thin lines border area extending 0.5 mm on eith
The Journal of Thoracic and Carhigher than the actual Aristotle score (23.2  3.4 vs 22.1 
2.9, P ¼ .08).
bPAB Outcome
No patient died intraoperatively. One patient required
a repeat operation to adjust the PA band. Prolonged pleural
effusion was observed in 1 case.
Eight infants underwent the NW with a Blalock-Taussig
shunt (BTS) or right ventricle-pulmonary artery shunt (four
each). An additional 8 patients underwent the NW simulta-
neously with a bidirectional Glenn operation (also termed
‘‘bidirectional cavopulmonary shunt’’ [BCPS]). In 1 of
the 8 NW with BCPS, a BTS had to be added because of
LPA stenosis. At the last follow-up, 1 of the 11 survivors
after BCPS placement had undergone the Fontan procedure,
and the other 10 were awaiting it.
Survival Rate After Discharge
One patient died 4 days after the NW, and 1 died of heart
failure in the hospital 103 days after the NW. The 30-day
survival rate after NW was 93.8%. The discharge mortality
and 90-day mortality rates were both 12.5%. All other chil-
dren were able to return home; however, 4 died suddenly at
home—1 of aspiration pneumonia and 3 of unknown causes
(Figure 4).
DISCUSSION
In patients with high-risk HLHS, the NW in the neonatal
period is still a challenging procedure that has high mortal-
ity.3 For this syndrome, a ‘‘hybrid operation’’ combining
bPAB and PDA stenting has recently been developed.15,16,18
The difficulty of bPAB is that 2 PA bands must be placed.
However, infants’ BWs vary greatly, from 2 to 3.5 kg or
even more; thus, we do not believe the same PA band size
would be suitable for all infants. Although the PA band of
the main PA is adjusted using the BW according to the
Trusler rule,19 no rule has been created to determine the
size for bPAB. We treated 17 patients requiring bPAB,
most of whom were able to undergo the NW. The exceptionry artery banding (bPAB) size and body weight (BW).Linear approximation
er side of thick line.
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FIGURE 3. Results of multivariate regression analysis indicating oxygen
saturation (SaO2) just before the Norwood operation (NW). Four factors
were used: banding size of right pulmonary artery (RPA), body weight
(BW) at bilateral pulmonary artery banding (bPAB), BW at the Norwood
operation (NW), and interval between bPAB and catheter examination.
Between actual SaO2 and estimated SaO2 was significant (R
2 ¼ 0.79).
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Thus, of our 17 patients, bPAB must have been performed
appropriately for single ventricular circulation—otherwise,
some of them would probably have stopped the treatment.
The PA in these 17 patients must have been well protected
by bPAB. An analysis of the bPAB data revealed that the
LPA had been adjusted to about the BW plus 7 mm
(Figure 2). Our findings have indicated that the RPA band
should have been 0.5 mm larger than the LPA. This was
not an accurate expression of size but a reasonably close es-
timate. In the operating room, the PA bands should be read-
justed to stabilize the SaO2. Intraoperative transesophageal
echocardiography can help in the adjustment of the banding
size by showing the blood flow pattern of the pulmonaryFIGURE 4. Flow chart of patients from bilateral pulmonary artery banding (b
1088 The Journal of Thoracic and Cardiovascular Survein. Since our analysis of these data, we have performed
bPAB in accordance with our standards. Not only have we
found no need to readjust the bPAB size, but also the pa-
tients have been very stable after bPAB.
In our hospital, PDA stent placement was performed in
some cases, but PDA stents sometimes appeared to be al-
most rupturing the PDA or were contraindicated because
of a stenotic aortic arch. Therefore, in patients with
HLHS, PDA stent placement is not always possible. In
the case of aortic atresia with a small transverse aortic
arch, a PDA stent can obstruct the backflow of blood from
the PDA into the ascending aorta and then into the coronary
arteries; thus PDA stent placement is risky. However, we
have not experienced such a case. We have recently used
lipoprostaglandin E1 administration tomaintain ductus arte-
riosus patency instead of PDA stent placement. However,
the patients treated with lipoprostaglandin E1 cannot go
home until the subsequent surgery has been completed;
thus, the cost of this approach might be great compared
with that of PDA stent placement. Patients receiving lipo-
prostaglandin E1 had no major complications in our study.
Despite the cost of the drug and hospitalization, the high de-
gree of safety and effectiveness of lipoprostaglandin E1
treatment make it worthy of serious consideration as an
alternative to a PDA stent. Using the formula for the esti-
mated SaO2, we can estimate the hospital stay before the
second-stage operation because we will know the size of
the PA band and BW at bPAB, assuming that the BW and
SaO2 at the NW are acceptable.
Once the PA blood flow has been controlled appropriately
by bPAB in patients with a nonstenotic PDA, the NW can be
delayed until infancy, because it is much safer in infants
than in neonates. The estimated Aristotle score of the NW
in the neonatal period is also higher than the actual score
in infancy, and the operative mortality of the NW after
bPAB has been satisfactory. If the children treated in the
present study had undergone the NW in the neonatal period,
the mortality would have been very high.20
The major problem of bPAB is postoperative PA stenosis.
Debanding might result in re-expansion of the PA, but thisPAB) to last medical checkup, showing number of patients at each stage.
gery c November 2010
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will not perform PA-plasty because the PA is too small
for a successful procedure to be performed. In 1 case,
BCPS placement was performed, but LPA stenosis re-
mained. In that case, a BTS was placed in the LPA. How-
ever, in the present study, no PA-plasty was performed.
After bPAB, the volume overload had decreased. If the
NWwith a BTS or a right ventricular-PA shunt is performed
after bPAB, the volume overload will increase again. It
could lead to deterioration of cardiac function; thus, care
is essential. In cases in which volume overload does occur,
the NW with a BCPS is a good option; however, sufficient
PA growth, including a lowPApressure, lowpulmonary vas-
cular resistance, and high PA index, is necessary. bPAB of-
ten causes PA stenosis, although not always severe; thus,
a disadvantage might exist in BCPS placement with the
NW. In patients with small PAs, we had to place a BTS, in-
stead of a BCPS, because a PA can be expected to grow
much more after placement of a BTS than after a BCPS. Re-
garding the Fontan procedure, at last follow-up, we had not
had enough cases and thus cannot comment. Only 1 patient
had undergone the complete Fontan procedure. This patient
had undergone the NW with BCPS placement after bPAB.
As for the Aristotle score, the variety of opinions is wide;
however, it is the only method for evaluating the operative
difficulty adjusted according to a patient’s preoperative risk
factors.21 In our study, the Aristotle comprehensive score
was compared with the estimated comprehensive Aristotle
score of the NW in the neonatal period; the latter was
slightly greater than the score in infancy. This concurs
with our opinion and is the reason we chose to perform
bPAB before the NW. We know that the Aristotle score re-
quires improvement; therefore, we intend to make a precise
calculation of the degree of the risk of surgery. This will be
helpful for surgeons to determine in advance the risk for
a particular patient.
In our cases of bPAB, the operative mortality after the
NW was quite low; however, death in the interim between
hospital stays is not always low. In patients with aortic atre-
sia (35%), a small ascending aorta is the only blood source
for the coronary arteries; thus, it acts as a type of single cor-
onary artery. The high risk of sudden death might be why
relatively many patients died at home between hospitaliza-
tions. We have been unable to determine the exact reason
for this high mortality, and we do not have any compelling
evidence of a potential relationship between bPAB and the
mortality between hospital stays. Additional investigation is
required. It is clear, however, that perioperative bPAB is
safe and minimizes the mortality of the NW in this high-
risk group.
The authors express their gratitude to Mr. C. W. P. Reynolds of
TokyoMedical University for his careful revision of the English of
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Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
Dr Kitahori, that was a very nice presentation.
Dr Kitahori has described a series of high-risk hypoplastic left
heart syndrome (HLHS) patients treated with bilateral pulmonary
artery (PA) banding (bPAB). He has tried to clarify the relationship
between the geometry of the PA band and arterial oxygen satura-
tion (SaO2) at the second-stage procedure.
In a fully grown neonate, this might not be as important because
numerous clinical reports have described the use of 3.5-mm diam-
eter polytetrafluoroethylene shunts wrapped around the branch
PAs.We have used this technique at the Hospital for Sick Children,
and it seems towork well. We have typically evaluated the banding
at the end of the procedure with angiography, but our approach has
been very subjective. Dr Kitahori is to be applauded for trying to
create some objective criteria for how to define these bands.
This is even more important in the small neonates in whom the
degree of banding is very difficult to adjust precisely. Small
changes in the circumference of a band will result in large changes
in the internal diameter and, consequently, even greater changes in
the resistance across the band.
We have competing interests in these small infants in that we
want the bands tight enough to restrict pulmonary blood flow, pre-
vent volume overload, and maintain adequate diastolic pressures,
and, at the same time, wewant the bands loose enough to allow ad-
equate SaO2 at banding and adequate SaO2 to be able to persist to
the time of the second-stage procedure, a difficult balancing act in
these very small infants. For that reason, this is an important con-
tribution because you are trying to define the relationship between
the geometry at banding and the subsequent SaO2.
As we discussed, I think the model would benefit if you could
create a model that was derived solely from variables determined
at bPAB. However, putting that aside, it would be a very valuable
addition and perhaps something you could study in the future.
With regard to questions regarding the presented data, I have 3.
First, could you describewhat clinical parameters are used when
the bands were constructed in your series. Each band reallymust be
assessed individually. Simply using the systemic SaO2 would be
inappropriate, because, as you know, you could have complete oc-
clusion of 1 pulmonary artery and a very loose band on the other
and have seemingly appropriate systemic SaO2. Thus, each band
really should be evaluated independently. How do you interrogate
the bands and determine the appropriate tightness of the bands?
Dr Kitahori. Thank you, Dr Caldarone.
The infants’ body weight varies so much, from 1.5 to 4 kg. This
is a very large difference. We thought the PA band should be ad-
justed to the suitable size, because the PA band on the main PA
trunk is adjusted according to Trusler’s rule. Mainly, we have mon-
itored the SaO2 in the operating room. In addition, we usually use
transesophageal echocardiography (TEE). TEE is also useful. Us-
ing TEE, we can see the pulmonary venous (PV) return well, and
we can check the balance of the right and left PV return. Also, the
bilateral PV return should be equivalent after bPAB. If the PV re-
turn of 1 side exceeds the other too much, the PA band should be
readjusted to be tighter or the other looser. However, we do not yet
have any clear criteria for the evaluation using TEE, such as the
exact value of the flow velocity of the PA band.We just see the bal-
ance. Although our TEE probe is the smallest available, it is some-1090 The Journal of Thoracic and Cardiovascular Surtimes difficult to measure the blood flow velocity in the PA
precisely, because the echoprobe direction does not always fit
the blood flow direction. In such cases, we could over- or underes-
timate the flow velocity. Thus, evaluation using TEE is a future
work for us—how to use TEE for the measurement of a precise
evaluation of the PA band.
Dr Caldarone. All right. Well, assuming that you have per-
fectly symmetric pulmonary artery bands, what is the appropriate
SaO2 at PA banding?
DrKitahori.We adjust the PA band with help of TEE. Our goal
for SaO2 is about 80% and 85% at maximum. In my opinion, the
SaO2 in the operating room should be in the slightly lower range,
meaning 80%, because the SaO2 usually gradually increases a little
bit after surgery. As you said, we want to reduce the volume over-
load as much as possible, but we have to keep the SaO2 at a good
level. Thus, the SaO2 must not be going to be quite low, which
would result in a lethal level. Thus, I think 80% would be good.
Dr Caldarone. My third question. In the manuscript you re-
ported that you administer prostaglandin to the infants from
bPAB to the second-stage procedure and thus you do not require
ductal stenting. This would eliminate the potential for duct-
induced stenosis of the aortic isthmus and thereby a problem
with retrograde flow in the aortic arch.
Two questions regarding that. First, did you have any complica-
tions associated with prolonged prostaglandin infusion? Second, at
the second-stage procedure, did you see any stenosis or other an-
atomic abnormality in the isthmus?
Dr Kitahori. The reported side effects of prostaglandin have
been apnea and thickening of the periosteum of the long bone.
One patient had an apnea attack, but it was not so severe, and re-
intubation was not needed. We have never observed thickening of
the periosteum of the long bone to date. In our institute, prostaglan-
din E1 administration is considered very safe and useful for main-
taining the patent ductus arteriosus (PDA). The only problem has
been the long hospital stay. Patients receiving prostaglandin can-
not go home. At that point, a PDA stent might be superior. How-
ever, it has some problems, as you mentioned. The PDA stent
can migrate and interfere with the blood flow of the transverse
arch. It is dangerous because the blood supply to coronary artery
is also interfered. In my opinion, the frequency of complications
related to prostaglandin might be smaller than that of the PDA
stent, so we chose prostaglandin.
Dr James S. Tweddell (Milwaukee, Wis). Can I just ask 1
follow-up question to Dr Caldarone. What is the fraction of inspi-
ratory oxygen when you are doing the banding?
Dr Kitahori. Usually the fraction of inspiratory oxygen is set
at 21%.
Dr Tweddell. 21%.
Dr Kitahori. That is room air.
Dr Tweddell. And normocapnia?
Dr Kitahori. Yes.
Dr Renato S. Assad (Sao Paulo, Brazil). I just would like to
share with the Association some comments about this technique.
We have used adjustable PA bands for high-risk patients with hy-
poplastic left heart syndrome, a simple method to percutaneously
regulate the pulmonary blood flow over time. Regarding our pro-
tocol of adjusting the PA bands in the operating room, the precise
degree of banding ring constriction is adjusted after sternalgery c November 2010
Kitahori et al Congenital Heart Diseaseclosure. Because we do not have TEE for small neonates, we ask
the anesthesiologist to keep the fraction of inspiratory oxygen in
the 21% to 30% range to be able to achieve SaO2 in the low 80s
during banding adjustment. That is our straightforward protocol
for PA banding adjustment, trying to administer the same amount
of volume in both banding cuffs to achieve similar blood flow to
both lungs. This system has allowed stable SaO2 in the low 80s
throughout the interstage 1-2.
Dr Kitahori. Thank you for your comments.
Dr Hideto Shimpo (Tsu, Mie, Japan). I congratulate
Dr Kitahori on very interesting data. I have a couple of questions.
Are there any differences between the RPA groups and the LPA
groups at the Fontan procedure?The Journal of Thoracic and CarDr Kitahori. Sometimes we have seen LPA stenosis, but it has
not been so severe. We did not need PA-plasty for LPA stenosis,
but it can be a problem of this technique. The PA band can cause
PA stenosis, especially at the PA banding site. However, we have
not needed any PA-plasty so far and have just inserted a dilator
into the LPA, which has been good enough.
Dr Shimpo.My second question: I think this technique is a very
good option for complex disease, so have you applied this tech-
nique to other complex diseases, for example, truncus arteriosis
and so on?
Dr Kitahori. I think bPAB is a good option for other dis-
eases, but we have few such cases. So, I cannot comment on
that, sorry.diovascular Surgery c Volume 140, Number 5 1091
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